News

Palantir and Databricks Announce Strategic Product Partnership to Deliver Secure and Efficient AI to Customers

Partnership combines Palantir\'s Artificial Intelligence Platform (AIP) and Databricks\' Data Intelligence Platform to accelerate the production of AI applications and reduce TCO

03-15

Bowtie and Gleneagles Hospital Hong Kong Collaborate to Upgrade VHIS Rider to Include Histotripsy Treatment In "Bowtie & Gleneagles Hospital Wellness Package"

Swift inclusion of innovative liver tumor treatment technology,lowers barriers for Hongkongers to access advanced medical services

03-15

MEXC Launches March Futures Competition with Prize Pool of Up to 8 Million USDT

Seychelles, March 12, 2025 – MEXC, a leading global cryptocurrency exchange, announces the upcoming launch of its March Futures Trading Competition. Set to run from March 13 to March 26, 2025, the competition features a prize pool of up to 8,000,000 USDT, offering traders an exciting opportunity to showcase their futures trading skills and compete for substantial rewards.

03-14

Green financial technology, GECC carbon assets, the code of green wealth!

03-14

China’s Economic Vitality Through Tax Data

On March 11, China’s State Taxation Administration released value-added tax (VAT) invoice data showing that from October 2024 to February 2025, the sales revenue growth rate of Chinese enterprises increased by 1.1 percentage points compared to the third quarter of 2024. This data reflects the diverse drivers and robust momentum of China’s economy.

03-14

10th Shanghai International Machine Tool Exhibition Breaks Records, Celebrates a Decade of Innovation

SHANGHAI,March 12,2025-- The 10th Shanghai International Machine Tool Exhibition (CMES),held from March 3-6,2025,concluded with record-breaking success,attracting 51,741 professional visitors (excludi

03-13

Mirae Asset Launches Global X Hang Seng TECH Components Covered Call Active ETF (3417)

Aim for Monthly Distributions (Dividend rate is not guaranteed,distributions may be made out of capital#)

03-13

STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States

STEQEYMA®,one of the first-wave biosimilars to STELARA®,is now available in the U.S. Approved for the same indications as the reference product,STEQEYMA will be priced with a wholesale acquis

03-13

ADEX OZTek Australia 2025: Dive into Innovation and Ocean Conservation

Sydney\'s Premier Event Unites Global Dive Community SYDNEY,March 12,2025-- From March 15–16,2025,theSydney International Convention and Exhibition Centrewill hostADEX OZTek Australia 2025,a landmark

03-13

Major Global Companies Pledge Historic Support to Triple Nuclear Energy

On the sidelines of CERAWeek 2025 in Houston,major companies join forces for the first time to launch a pioneering cross-sector pledge to emphasize nuclear energy\'s essential role in enhancing energy

03-13

Home Previous 70 71 72 73 74 75 76 Next Tail

10 Items Per Page (Page 73 / 529) Total 5290 Items

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright2009-2020Fresh life